Literature DB >> 30264301

[Sarcoidosis triggered by immune checkpoint blockade].

Markus Heppt1, Anne-Charlotte Niesert2, Michael Flaig2, Carola Berking2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30264301     DOI： 10.1007/s00105-018-4186-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  6 in total

1.  Cutaneous and pulmonary sarcoidosis-like reaction associated with ipilimumab.

Authors:  Ross B Reule; Jeffrey P North
Journal:  J Am Acad Dermatol       Date:  2013-11       Impact factor: 11.527

2.  Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient.

Authors:  A Eckert; A Schoeffler; S Dalle; A Phan; L Kiakouama; L Thomas
Journal:  Dermatology       Date:  2008-10-02       Impact factor: 5.366

3.  New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment.

Authors:  Kevin P Murphy; Marcus P Kennedy; Josephine E Barry; Kevin N O'Regan; Derek G Power
Journal:  Oncol Res Treat       Date:  2014-05-12       Impact factor: 2.825

4.  Sarcoidosis induced by interferon-α in melanoma patients: incidence, clinical manifestations, and management strategies.

Authors:  Lucie M Heinzerling; Mark D Anliker; Joachim Müller; Marc Schlaeppi; Roger von Moos
Journal:  J Immunother       Date:  2010-10       Impact factor: 4.456

5.  Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.

Authors:  Nicole A Braun; Lindsay J Celada; Jose D Herazo-Maya; Susamma Abraham; Guzel Shaginurova; Carla M Sevin; Jan Grutters; Daniel A Culver; Ryszard Dworski; James Sheller; Pierre P Massion; Vasiliy V Polosukhin; Joyce E Johnson; Naftali Kaminski; David S Wilkes; Kyra A Oswald-Richter; Wonder P Drake
Journal:  Am J Respir Crit Care Med       Date:  2014-09-01       Impact factor: 21.405

6.  Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature.

Authors:  Joshua E Reuss; Paul R Kunk; Anne M Stowman; Alejandro A Gru; Craig L Slingluff; Elizabeth M Gaughan
Journal:  J Immunother Cancer       Date:  2016-12-20       Impact factor: 13.751
  6 in total
  1 in total

1.  Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.

Authors:  Colm Kirby; Darragh Herlihy; Lindsey Clarke; Ronan Mullan
Journal:  BMJ Case Rep       Date:  2021-02-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.